Prelude Therapeutics Incorporated (PRLD) has 18 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est ORBIMED ADVISORS LLC avec 10,119,756 actions. Parmi les autres détenteurs notables Vaddi Krishna et Lim Bryant David.
Au cours des 12 derniers mois, les initiés ont effectué 16 transactions sur PRLD l'action — 11 achats (d'une valeur de $4.06M) et 0 ventes (d'une valeur de RSU Award). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.
PRLD Participations des Initiés
Principal Actionnaire
ORBIMED ADVISORS LLC
10,119,756 actions
Achats (12 mois)
11
$4.06M valeur
Ventes (12 mois)
0
$0.00 valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Orbimed Advisors Llc |
10 Percent Owner |
10,119,756 |
2023-05-24 |
|
| 2 |
Vaddi Krishna |
CEO |
837,000 |
2026-02-05 |
|
| 3 |
Lim Bryant David |
CLO, CFO, Corp Sec. |
275,000 |
2026-02-05 |
|
| 4 |
Scherle Peggy |
Chief Scientific Officer |
230,000 |
2026-02-05 |
|
| 5 |
Combs Andrew |
Chief Chemistry Officer |
230,000 |
2026-02-05 |
|
| 6 |
Chardonnet Laurent |
Chief Financial Officer |
150,000 |
2024-03-04 |
|
| 7 |
Sandor Victor |
Director |
121,285 |
2025-11-07 |
|
| 8 |
Piper Brian |
Chief Financial Officer |
115,650 |
2021-07-22 |
|
| 9 |
Mauro David J |
Chief Medical Officer |
95,000 |
2021-07-22 |
|
| 10 |
Morosini Deborah |
EVP, Chief of Clinical Affairs |
90,000 |
2022-02-17 |
|
| 11 |
Baker Bros. Advisors Lp |
10 Percent Owner |
76,000 |
2025-06-13 |
|
| 12 |
Dier Mardi |
Director |
38,000 |
2025-06-13 |
|
| 13 |
Bonita David P |
10 Percent Owner |
38,000 |
2025-06-13 |
|
| 14 |
Babler Martin |
Director |
38,000 |
2025-06-13 |
|
| 15 |
Friedman Paul A |
Director |
38,000 |
2025-06-13 |
|
| 16 |
Baker Brothers Life Sciences Lp |
Director |
34,300 |
2022-06-22 |
|
| 17 |
Huang Jane |
President, CMO |
18,750 |
2025-10-07 |
|
| 18 |
Pierce Christopher |
EVP and Chief of Business Oper |
3,750 |
2021-09-07 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-03-05 |
Brusky Sean P. |
Chief Business Officer |
Inconnu |
275,000 |
- |
- |
| 2026-02-04 |
Combs Andrew |
Chief Chemistry Officer |
Attribution de RSU |
230,000 |
$2.30 |
$529K |
| 2026-02-04 |
Vaddi Krishna |
CEO |
Attribution de RSU |
837,000 |
$2.30 |
$1.93M |
| 2026-02-04 |
Scherle Peggy |
Chief Scientific Officer |
Attribution de RSU |
230,000 |
$2.30 |
$529K |
| 2026-02-04 |
Lim Bryant David |
CLO, CFO, Corp Sec. |
Attribution de RSU |
275,000 |
$2.30 |
$632.5K |
| 2025-11-05 |
Sandor Victor |
Director |
Attribution de RSU |
121,285 |
$1.39 |
$168.59K |
| 2025-10-17 |
Dorton Katina |
Officer |
Inconnu |
- |
- |
- |
| 2025-10-04 |
Huang Jane |
President, CMO |
Exercice d'Options (Vente) |
9,375 |
- |
- |
| 2025-07-04 |
Huang Jane |
President, CMO |
Exercice d'Options (Vente) |
9,375 |
- |
- |
| 2025-06-12 |
Scherer Paul C |
Officer |
Inconnu |
- |
- |
- |
| 2025-06-12 |
Sandor Victor |
Director |
Attribution de RSU |
38,000 |
$1.04 |
$39.52K |
| 2025-06-12 |
Dier Mardi |
Director |
Attribution de RSU |
38,000 |
$1.04 |
$39.52K |
| 2025-06-12 |
Bonita David P |
10 Percent Owner |
Attribution de RSU |
38,000 |
$1.04 |
$39.52K |
| 2025-06-12 |
Babler Martin |
Director |
Attribution de RSU |
38,000 |
$1.04 |
$39.52K |
| 2025-06-12 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Attribution de RSU |
76,000 |
$1.04 |
$79.04K |
| 2025-06-12 |
Friedman Paul A |
Director |
Attribution de RSU |
38,000 |
$1.04 |
$39.52K |
Les autres consultent aussi
